Regulations.gov document
Reconsideration Citizen Petition Request declare that Fasprofen fast dissolving tablets…
Other · FDA-2012-P-1112 · posted Jan 28, 2015
Key facts
| Document ID | FDA-2012-P-1112-0007 |
|---|---|
| Title | Reconsideration Citizen Petition Request declare that Fasprofen fast dissolving tablets 100 mg are suitable for submission as an AND A. The Reference Listed Drug RLD product on which this petition is based is Motrin ibuprofen 100 mg chewable tablets. |
| Document type | Other |
| Subtype | Petition for Reconsideration |
| Agency | FDA |
| Docket | FDA-2012-P-1112 |
| Posted | Jan 28, 2015 |
| Comment period opens | Jan 28, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: